Valuation: H&R GmbH & Co KgaA

Market Cap 23Cr 26Cr 21Cr 19Cr 36Cr 2.49TCr 37Cr 249.49Cr 98Cr 1.22TCr 97Cr 95Cr 4.19TCr P/E 2026 *
38.7x
P/E 2027 * 28.5x
Enterprise Value 38Cr 44Cr 35Cr 33Cr 62Cr 4.2TCr 63Cr 421.58Cr 165.41Cr 2.06TCr 164.37Cr 160.74Cr 7.09TCr EV / Sales 2026 *
0.3x
EV / Sales 2027 * 0.29x
Free-Float
21.97%
Yield 2026 *
0.82%
Yield 2027 * 0.82%
15/05 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
31/03 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/01 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
15/11 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/11 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/25/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/25/15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/25/16 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/25/14 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/25/17 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/25/09 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
27/25/27 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
27/25/27 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26Cr
+1.01%+0.19%+12.30%+34.28% 13TCr
+5.26%+13.51%+687.99%+200.43% 4.92TCr
-0.29%+1.06%-4.90%-40.78% 4.19TCr
+3.96%-2.00%+24.91%-24.06% 3.09TCr
+6.32%+4.26%+41.22%+64.53% 2.22TCr
+0.11%+6.67%-7.61%-36.00% 1.88TCr
+0.55%-7.97%+334.23%+568.91% 1.71TCr
+0.72%-1.36%+18.59%+398.91% 1.72TCr
+2.12%-12.64%+60.37%+196.54% 1.67TCr
Average +1.98%+3.20%+129.68%+151.42% 3.8TCr
Weighted average by Cap. +2.04%+4.03%+128.05%+94.80%

Financials

2026 *2027 *
Net sales 129.35Cr 148.01Cr 119.58Cr 110.47Cr 208.04Cr 14TCr 211.81Cr 1.43TCr 559.48Cr 6.96TCr 555.97Cr 543.69Cr 24TCr 133.02Cr 152.22Cr 122.97Cr 113.61Cr 213.95Cr 15TCr 217.83Cr 1.47TCr 575.38Cr 7.16TCr 571.77Cr 559.13Cr 25TCr
Net income 58.49L 66.93L 54.07L 49.95L 94.07L 64Cr 95.77L 6.45Cr 2.53Cr 31Cr 2.51Cr 2.46Cr 108.39Cr 79.95L 91.49L 73.91L 68.28L 1.29Cr 88Cr 1.31Cr 8.81Cr 3.46Cr 43Cr 3.44Cr 3.36Cr 148.16Cr
Net Debt 16Cr 18Cr 14Cr 13Cr 25Cr 1.72TCr 26Cr 172.1Cr 68Cr 840.2Cr 67Cr 66Cr 2.89TCr 16Cr 18Cr 15Cr 13Cr 25Cr 1.73TCr 26Cr 174Cr 68Cr 849.47Cr 68Cr 66Cr 2.92TCr
Logo H&R GmbH & Co KgaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-